Cat. No JK933178_1_ML
J&K Chemical

Product Information

Product Name
Roxithromycin in methanol, reference material, 100 μg/mL
Brand Name
J&K
Product Number
933178
CAS
80214-83-1
Molecular Formula
C41H76N2O15
Molecular Weight
837.05
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
6915744
IUPAC Name
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yloxy-14-ethyl-7,12,13-trihydroxy-4-(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yloxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
InChI Key
RXZBMPWDPOLZGW-XMRMVWPWSA-N
SMILES
CCC@@H1C@@(C@@H(C@H(/C(=N/OCOCCOC)/C@@H(CC@@(C@@H(C@H(C@@H(C@H(C(=O)O1)C)OC@H2CC@@(C@H(C@@H(O2)C)O)(C)OC)C)OC@H3C@@H(C@H(CC@H(O3)C)N(C)C)O)(C)O)C)C)O)(C)O

Properties

Melting Point
111-118
Flash Point
>110

Safety Information

GHS Symbols
Hazard Symbol
Hazard Statement
H302
Precautionary Statement
P264
P270
P330
P501
P301+P317
Storage Condition
Store at 2-8℃

References Data Source From Pubchem

Evaluation of Roxithromycin as a Treatment Option for Small Abdominal Aortic Aneurysms: An Integrated Study of Meta-analysis and Network Pharmacology

Publication Name: Current Medicinal Chemistry
Publication Date: 2025-04
DOI: 10.2174/0109298673267204231115105934

The Non-Antibacterial Effects of Azithromycin and Other Macrolides on the Bronchial Epithelial Barrier and Cellular Differentiation

Publication Name: International Journal of Molecular Sciences
Publication Date: 2025-03-04
DOI: 10.3390/ijms26052287

The key molecular mechanisms of antagonism induced by combined exposure to erythromycin and roxithromycin in Chlorella pyrenoidosa

Publication Name: Aquatic toxicology (Amsterdam, Netherlands)
Publication Date: 2025-03
DOI: 10.1016/j.aquatox.2025.107269

Simultaneous degradation of roxithromycin and nitrogen removal by Acinetobacter pittii TR1: Performances, pathways, and mechanisms

Publication Name: Journal of Environmental Management
Publication Date: 2025-02
DOI: 10.1016/j.jenvman.2024.123890

Enteric Microcapsules Encapsulation of Roxithromycin-PVP Composite Core Particles to Inhibit Drug Crystallization upon Fluidized Bed Method for Oral Administration

Publication Name: Chemical and Pharmaceutical Bulletin
Publication Date: 2024-12-20
DOI: 10.1248/cpb.c24-00608

Roxithromycin in methanol, reference material, 100 μg/mL

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page